VIATORR Device Registry

Active, not recruitingOBSERVATIONAL
Enrollment

196

Participants

Timeline

Start Date

February 21, 2023

Primary Completion Date

March 31, 2028

Study Completion Date

December 31, 2028

Conditions
Chronic Liver Disease
Interventions
DEVICE

Transjugular intrahepatic portosystemic shunt

The GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion is indicated for use in the treatment of portal hypertension and its complications such as variceal bleeding and refractory ascites. The GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion is a current generation of the GORE® VIATORR® TIPS Endoprosthesis. The GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion was designed to build on the success of the GORE® VIATORR® TIPS Endoprosthesis. The GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion allows for intraoperative diameter control to reach a targeted portal pressure gradient.

Trial Locations (7)

41125

University Hospital Modena, Modena

48149

Westfälische Wilhelms-Universität Münster, Münster

50134

AOU Careggi, Florence

75013

Hôpital La Pitiè-Salpétrière, Paris

79106

University Medical Center Freiburg, Department of Medicine II, Freiburg im Breisgau

18-A-1090

Medical University of Vienna - Department of Internal Medicine III, Vienna

08036

Hospital Clinic Barcelona, Barcelona

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY